MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P40
Within normal range
vs 2Y Ago
-2.9x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-68.12%
2024-172.54%
202323.47%
2022-58.90%
2021-11007.07%
20200.00%